Recently, the European Association of Urology Guidelines Panel updated the prognostic factor risk groups model for non-muscle-invasive bladder cancer (NMIBC) with the introduction of a new group of patients at Very high risk (VHR). Furthermore, three additional clinical risk factors (i.e., age > 70 years, multiple papillary tumors; tumor diameter > 3 cm) were proposed. However, the new scoring model was created by analyzing data from patients who did not receive BCG intravesical therapy.
Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG
Cantiello, FrancescoMembro del Collaboration Group
;Damiano, Rocco;
2022-01-01
Abstract
Recently, the European Association of Urology Guidelines Panel updated the prognostic factor risk groups model for non-muscle-invasive bladder cancer (NMIBC) with the introduction of a new group of patients at Very high risk (VHR). Furthermore, three additional clinical risk factors (i.e., age > 70 years, multiple papillary tumors; tumor diameter > 3 cm) were proposed. However, the new scoring model was created by analyzing data from patients who did not receive BCG intravesical therapy.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
